Financial Gravity Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11
Closed -$19 1217
2022
Q4
$19 Buy
+11
New +$163 ﹤0.01% 1320
2019
Q4
Sell
-8
Closed 1411
2019
Q3
$0 Buy
+8
New +$222 ﹤0.01% 1218

Other funds holding CDNA

Financial Gravity Asset Management's CDNA Position: Q1 2023 in Review

Financial Gravity Asset Management sold out of CareDx (CDNA) in Q1 2023, closing a stake of 11 shares — an estimated $19 sold.

Financial Gravity Asset Management first reported a position in CDNA in Q3 2019 and held it in 2 quarters. The position peaked at $19 in Q4 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Financial Gravity Asset Management reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 11 CareDx shares in Q1 2023, an estimated $19.
  • Financial Gravity Asset Management first reported a position in CareDx in Q3 2019 and held it in 2 quarters.
  • Financial Gravity Asset Management's CareDx position peaked at $19 in Q4 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Financial Gravity Asset Management's 13F filing for Q1 2023, filed 12 May 2023.